# Q1 Journal Peer Review Report

## Reviewers
- **Reviewer 1**: Econometrics Specialist (OpenAI GPT-4o)
- **Reviewer 2**: Healthcare Finance Expert (Claude Opus 4.5)
- **Reviewer 3**: Public Sector Finance Specialist (Gemini 2.0)

---

## Score Summary

| Criterion | Weight | R1 | R2 | R3 | Average |
|-----------|--------|----|----|----|---------| 
| Research Question | 10% | 18 | 15 | 17 | 16.7 |
| Literature Review | 10% | 16 | 15 | 16 | 15.7 |
| Theoretical Framework | 10% | 14 | 14 | 15 | 14.3 |
| Methodology Design | 15% | 12 | 13 | 13 | 12.7 |
| Data Quality | 10% | 17 | 16 | 18 | 17.0 |
| Empirical Analysis | 20% | 13 | 14 | 14 | 13.7 |
| Results Interpretation | 10% | 14 | 12 | 16 | 14.0 |
| Replicability | 5% | 19 | 18 | 20 | 19.0 |
| Writing Quality | 5% | 16 | 15 | 18 | 16.3 |
| Ai Tools Usage | 5% | 15 | 17 | 18 | 16.7 |

---

## Overall Recommendations

**Reviewer 1: Econometrics Specialist (GPT-4o)**
- Recommendation: ACCEPT_WITH_MAJOR_REVISIONS
- Score: 15.8/20
- Assessment: The paper addresses a timely and policy-relevant question regarding the financial impact of healthcare integration in Portugal. While the methodological transparency and replicability are commendable, significant issues with identification, statistical power, and short observation periods limit the causal claims. Major revisions are needed to strengthen the theoretical framework and empirical strategy.

**Reviewer 2: Healthcare Finance Expert (Claude Opus 4.5)**
- Recommendation: ACCEPT_WITH_MAJOR_REVISIONS
- Score: 14.3/20
- Assessment: This revised manuscript represents a thoughtful response to first-round concerns, particularly in reframing the contribution and acknowledging limitations. The methodological infrastructure is commendable, and the transparency about statistical constraints is exemplary for the field. However, the fundamental identification problem remains unresolved—pre-existing ULS as controls are conceptually problematic—and the paper still overpromises relative to what the empirical design can credibly deliver.

**Reviewer 3: Public Sector Finance (Gemini 2.0)**
- Recommendation: ACCEPT_WITH_MAJOR_REVISIONS
- Score: 15.75/20
- Assessment: This is a methodologically sophisticated execution of a fundamentally constrained natural experiment. The author demonstrates high competence in transparency, replicability, and identifying limitations, effectively pivoting the paper from a causal evaluation (which the data cannot support) to a baseline study. However, the severe power limitations and the structural non-comparability of the control group remain significant hurdles for a Q1-level contribution.

---

## Consensus Priority Revisions

1. Revision 1: Address the fundamental identification problem by implementing alternative identification strategies.
2. Revision 2: Conduct a formal power analysis and integrate its implications into the results interpretation.
3. Revision 3: Extend the theoretical framework to include explicit hypotheses about effect magnitudes and timing.
4. Complete the manuscript: The paper is truncated mid-section, missing results presentation, heterogeneity analyses, discussion, policy implications, and conclusions. These are essential components that cannot be evaluated in current form.
5. Reframe the identification strategy and estimand: Explicitly acknowledge that you are comparing short-run integration effects (newly integrated) vs. long-run integration effects (established ULS), not integration vs. no integration. This changes the policy interpretation substantially—you're estimating a within-treatment timing comparison, not a treatment vs. control comparison.
6. Elevate the selection pattern as the primary finding: The 18.5pp baseline difference and the documentation of non-random early adoption is your most robust finding. Build the discussion around what this tells us about (a) why early regions were selected, (b) implications for interpreting integration effects, and (c) external validity for future ULS evaluations.
7. Revision 1: Strengthen the Synthetic Control validation. With only 7 donors, you must demonstrate that a valid convex combination actually exists. Show the pre-treatment fit metrics (RMSPE) clearly. If the fit is poor, acknowledge that SC fails.
8. Revision 2: Elevate the 'Selection Bias' finding. The fact that early ULS were structurally different (rural/distressed) is a positive empirical finding about political economy, not just a methodological limitation. Analyze *why* these were chosen first.
9. Revision 3: Refine the Power Analysis interpretation. Instead of just stating power is low, calculate the 'ex-post Minimum Detectable Effect' (MDE) given your standard errors. Show exactly how massive the effect would have needed to be for you to see it.

---

## Identified Fatal Flaws

**Reviewer 1: Econometrics Specialist (GPT-4o):**
- Fundamental identification problem with pre-existing ULS as 'differently treated' rather than 'untreated' units.
- Severe underpowering (~25% power) makes null findings uninformative.
- Short post-reform period (12 months) is insufficient to detect organizational effects.

**Reviewer 2: Healthcare Finance Expert (Claude Opus 4.5):**
- The identification strategy remains fundamentally compromised: pre-existing ULS (created 12-25 years ago) are 'long-run treated' units, not 'untreated' controls, making the DiD estimand unclear—the paper estimates the difference between short-run and long-run integration effects, not the effect of integration per se.
- The paper is truncated mid-section (cuts off at 'The selection pattern'), preventing full evaluation of results, heterogeneity analyses, and policy implications—essential components for assessing the contribution.
- With only 7 control units and 25% statistical power, the inferential framework cannot distinguish between null effects, small positive effects, and small negative effects, yet the paper still draws policy-relevant conclusions from these uninformative results.

**Reviewer 3: Public Sector Finance (Gemini 2.0):**
- Statistical power is critically low (25%), rendering the failure to reject the null hypothesis scientifically uninformative rather than evidence of 'no effect'.
- The control group (pre-existing ULS) is not just 'differently treated' but structurally distinct (predominantly rural/low-density), creating a violation of the parallel trends assumption that may not be solvable even with Synthetic Control given the small donor pool.


---

*Report generated: January 2026*
